Pei‐Fang Su

ORCID: 0000-0002-1149-8022 · 3 papers in corpus
2025
Medicina (Kaunas, Lithuania) ·doi:10.3390/medicina61091571

Background and Objectives: Live birth rates in women with diminished ovarian reserve (AMH < 2.0 ng/mL) undergoing in vitro fertilization (IVF) remain under 20%. While Chinese herbal medicine (CHM) is often used to treat infertility and supp…

article 2023
Taiwanese journal of obstetrics & gynecology ·doi:10.1016/j.tjog.2022.12.012

OBJECTIVE: This study aimed to assess the effect of atosiban on in vitro fertilization (IVF) pregnancy outcome among women with both endometriosis and adenomyosis, and compared it to that of patients with endometriosis but without adenomyos…

preprint 2021
·doi:10.21203/rs.3.rs-963721/v1

Abstract BackgroundThe use of atosiban during embryo transfer (ET), an oxytocin receptor antagonist, has been demonstrated to enhance pregnancy rate among infertile patients with endometriosis. However, its efficacy has not been assessed am…